Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 22(20)2021 Oct 15.
Article in English | MEDLINE | ID: mdl-34681781

ABSTRACT

In this paper, we examined the effects of melittin, a bee venom membrane-active peptide, on mitochondrial respiration and cell viability of healthy human lymphocytes (HHL) and Jurkat cells, as well as on lymphoblasts from acute human T cell leukemia. The viability of melittin-treated cells was related to changes in O2 consumption and in the respiratory control index (RCI) of mitochondria isolated from melittin-pretreated cells as well as of mitochondria first isolated from cells and then directly treated with melittin. It was shown that melittin is three times more cytotoxic to Jurkat cells than to HHL, but O2 consumption and RCI values of mitochondria from both cell types were equally affected by melittin when melittin was directly added to mitochondria. To elucidate the molecular mechanism of melittin's cytotoxicity to healthy and cancer cells, the effects of melittin on lipid-packing and on the dynamics in model plasma membranes of healthy and cancer cells, as well as of the inner mitochondrial membrane, were studied by EPR spin probes. The affinity of melittin binding to phosphatidylcholine, phosphatidylserine, phosphatidic acid and cardiolipin, and binding sites of phospholipids on the surface of melittin were studied by 31P-NMR, native PAGE and AutoDock modeling. It is suggested that the melittin-induced decline of mitochondrial bioenergetics contributes primarily to cell death; the higher cytotoxicity of melittin to cancer cells is attributed to its increased permeability through the plasma membrane.


Subject(s)
Lymphocytes/drug effects , Melitten/pharmacology , Mitochondria/drug effects , Mitochondrial Membranes/drug effects , Bee Venoms/chemistry , Blood Cells/drug effects , Blood Cells/metabolism , Cell Respiration/drug effects , Cells, Cultured , Humans , Jurkat Cells , Lipid Bilayers/chemistry , Lymphocytes/metabolism , Melitten/isolation & purification , Mitochondria/physiology , Mitochondrial Membranes/metabolism , Mitochondrial Membranes/ultrastructure , Models, Biological , Permeability/drug effects
2.
Regul Toxicol Pharmacol ; 126: 105047, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34506878

ABSTRACT

Modern perspectives on the risk assessment of carcinogenic potential of chemicals have taken shape within the last two decades. This has been due to both developments in the understanding of the biology and etiology of cancer and by advances in in silico and in vitro assays. Moving away from a conventional binary carcinogen/non-carcinogen model, modern frameworks offer more nuanced classification structures based on the understanding of mechanisms involved or potentially involved in rodent carcinogenicity. Given these developments, a scientific session at the 2020 Winter Meeting of the Toxicology Forum was organized to explore the impact these innovative approaches will have on food safety assessments and what considerations should be addressed in developing a new carcinogenic risk assessment approach for substances in foods. The session reviewed challenges faced by food toxicologists and risk assessors, current standard approaches for evaluating carcinogenic risk of food substances, limitations of these standard approaches, and potential methods to implement next generation assays and modern carcinogenic frameworks into food safety assessments. Current perspectives of US regulatory, industry, and academic stakeholders were represented during speaker presentations and a moderated Panel Discussion. This Workshop Report provides an overview of key themes and information presented during the session. Summary statements were prepared by the authors and reviewed by the presenters but do not necessarily represent the position or policy of the FDA, the EPA, or other affiliations.


Subject(s)
Carcinogens/standards , Food/standards , Animals , Carcinogenicity Tests , Humans , Risk Assessment , Rodentia , United States , United States Food and Drug Administration
3.
Crit Rev Food Sci Nutr ; 61(6): 959-970, 2021.
Article in English | MEDLINE | ID: mdl-32274948

ABSTRACT

Over the past several decades, the use of genetically engineered microorganisms (GEMs, often referred to as Genetically Modified Microorganisms or GMMs) has become widespread in the production of food processing aids and other food ingredients. GEMs are advancing food production by increasing efficiency, reducing waste and resource requirements, and ultimately enabling beneficial innovations such as the cost-effective fortification of food with essential nutrients, vitamins, and amino acids, and delivery of tailored enzymes to achieve unique food processing capabilities. Regulatory agencies, including those in the European Union, United States, and Canada review the safety of GEMs when evaluating food substances produced using GEMs to ensure that both the microorganism and the resulting food substance are safe. This paper provides a summary of historical and current use of GEMs in food manufacture, an overview of frameworks that regulate their use, and a description of the safety assessment of both GEMs and food substances produced with GEMs. The paper encourages regulatory agencies around the globe to take a more aligned approach to the safety evaluation and regulatory oversight of GEM-produced food ingredients and enzymes, a category of food substances that enables more sustainable consumer food choices.


Subject(s)
Food Handling , Genetic Engineering , Canada , European Union , United States
4.
Toxins (Basel) ; 12(7)2020 06 27.
Article in English | MEDLINE | ID: mdl-32605112

ABSTRACT

Cardiotoxin CTII from Najaoxiana cobra venom translocates to the intermembrane space (IMS) of mitochondria to disrupt the structure and function of the inner mitochondrial membrane. At low concentrations, CTII facilitates ATP-synthase activity, presumably via the formation of non-bilayer, immobilized phospholipids that are critical in modulating ATP-synthase activity. In this study, we investigated the effects of another cardiotoxin CTI from Najaoxiana cobra venom on the structure of mitochondrial membranes and on mitochondrial-derived ATP synthesis. By employing robust biophysical methods including 31P-NMR and 1H-NMR spectroscopy, we analyzed the effects of CTI and CTII on phospholipid packing and dynamics in model phosphatidylcholine (PC) membranes enriched with 2.5 and 5.0 mol% of cardiolipin (CL), a phospholipid composition that mimics that in the outer mitochondrial membrane (OMM). These experiments revealed that CTII converted a higher percentage of bilayer phospholipids to a non-bilayer and immobilized state and both cardiotoxins utilized CL and PC molecules to form non-bilayer structures. Furthermore, in order to gain further understanding on how cardiotoxins bind to mitochondrial membranes, we employed molecular dynamics (MD) and molecular docking simulations to investigate the molecular mechanisms by which CTII and CTI interactively bind with an in silico phospholipid membrane that models the composition similar to the OMM. In brief, MD studies suggest that CTII utilized the N-terminal region to embed the phospholipid bilayer more avidly in a horizontal orientation with respect to the lipid bilayer and thereby penetrate at a faster rate compared with CTI. Molecular dynamics along with the Autodock studies identified critical amino acid residues on the molecular surfaces of CTII and CTI that facilitated the long-range and short-range interactions of cardiotoxins with CL and PC. Based on our compiled data and our published findings, we provide a conceptual model that explains a molecular mechanism by which snake venom cardiotoxins, including CTI and CTII, interact with mitochondrial membranes to alter the mitochondrial membrane structure to either upregulate ATP-synthase activity or disrupt mitochondrial function.


Subject(s)
Cobra Cardiotoxin Proteins/metabolism , Elapid Venoms/toxicity , Mitochondria, Heart/drug effects , Mitochondrial Membranes/drug effects , Mitochondrial Proton-Translocating ATPases/metabolism , Naja naja , Phospholipids/metabolism , Animals , Binding Sites , Cattle , Cobra Cardiotoxin Proteins/toxicity , Elapid Venoms/metabolism , Membranes, Artificial , Mitochondria, Heart/enzymology , Mitochondrial Membranes/enzymology , Molecular Docking Simulation , Molecular Dynamics Simulation , Protein Binding , Time Factors
5.
Arch Toxicol ; 92(1): 15-40, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29302712

ABSTRACT

Exposure assessment is a fundamental part of the risk assessment paradigm, but can often present a number of challenges and uncertainties. This is especially the case for process contaminants formed during the processing, e.g. heating of food, since they are in part highly reactive and/or volatile, thus making exposure assessment by analysing contents in food unreliable. New approaches are therefore required to accurately assess consumer exposure and thus better inform the risk assessment. Such novel approaches may include the use of biomarkers, physiologically based kinetic (PBK) modelling-facilitated reverse dosimetry, and/or duplicate diet studies. This review focuses on the state of the art with respect to the use of biomarkers of exposure for the process contaminants acrylamide, 3-MCPD esters, glycidyl esters, furan and acrolein. From the overview presented, it becomes clear that the field of assessing human exposure to process-related contaminants in food by biomarker monitoring is promising and strongly developing. The current state of the art as well as the existing data gaps and challenges for the future were defined. They include (1) using PBK modelling and duplicate diet studies to establish, preferably in humans, correlations between external exposure and biomarkers; (2) elucidation of the possible endogenous formation of the process-related contaminants and the resulting biomarker levels; (3) the influence of inter-individual variations and how to include that in the biomarker-based exposure predictions; (4) the correction for confounding factors; (5) the value of the different biomarkers in relation to exposure scenario's and risk assessment, and (6) the possibilities of novel methodologies. In spite of these challenges it can be concluded that biomarker-based exposure assessment provides a unique opportunity to more accurately assess consumer exposure to process-related contaminants in food and thus to better inform risk assessment.


Subject(s)
Biomarkers/analysis , Dietary Exposure/analysis , Food Contamination/analysis , Food Handling , Acrolein/blood , Acrolein/chemistry , Acrolein/urine , Acrylamide/blood , Acrylamide/chemistry , Acrylamide/urine , Animals , Furans/blood , Furans/chemistry , Furans/urine , Humans , Models, Biological , Risk Assessment/methods , alpha-Chlorohydrin/chemistry , alpha-Chlorohydrin/urine
6.
Food Chem Toxicol ; 107(Pt A): 522, 2017 09.
Article in English | MEDLINE | ID: mdl-28668441
7.
Int J Toxicol ; 35(3): 358-70, 2016 05.
Article in English | MEDLINE | ID: mdl-27102178

ABSTRACT

Processing (eg, cooking, grinding, drying) has changed the composition of food throughout the course of human history; however, awareness of process-formed compounds, and the potential need to mitigate exposure to those compounds, is a relatively recent phenomenon. In May 2015, the North American Branch of the International Life Sciences Institute (ILSI North America) Technical Committee on Food and Chemical Safety held a workshop on the risk-based process for mitigation of process-formed compounds. This workshop aimed to gain alignment from academia, government, and industry on a risk-based process for proactively assessing the need for and benefit of mitigation of process-formed compounds, including criteria to objectively assess the impact of mitigation as well as research needed to support this process. Workshop participants provided real-time feedback on a draft framework in the form of a decision tree developed by the ILSI North America Technical Committee on Food and Chemical Safety to a panel of experts, and they discussed the importance of communicating the value of such a process to the larger scientific community and, ultimately, the public. The outcome of the workshop was a decision tree that can be used by the scientific community and could form the basis of a global approach to assessing the risks associated with mitigation of process-formed compounds.


Subject(s)
Decision Trees , Food Contamination/prevention & control , Food Handling , Animals , Food Safety , Humans , Risk Assessment
8.
Food Chem Toxicol ; 74: 343-8, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25445760

ABSTRACT

One of the most abundant oligosaccharides found in human milk is 2'-fucosyllactose, a trisaccharide composed of fucose and lactose, and multiple studies have demonstrated a health benefit to this compound. Recent advances have allowed for the large-scale production of oligosaccharides via fermentation, including 2'-fucosyllactose. A neonatal piglet model was used to evaluate the tolerability of 2'-fucosyllactose, produced through this process, in order to demonstrate the suitability of this compound for human infants under 12 weeks of age. Crossbred farm piglets, at lactation day 2, were assigned to one of four treatment groups receiving a liquid diet containing 0, 200, 500 or 2000 mg/L of 2'-fucosyllactose. The calculated consumption of 2'-fucosyllactose corresponded to dose levels of 29.37, 72.22 and 291.74 mg/kg/day, respectively, in males and 29.30, 74.31, and 298.99 mg/kg/day, respectively in females. Piglets were administered diet for 3 weeks; and there were no test article-related effects on growth and development (clinical observations, body weight and food consumption), clinical pathology parameters (hematology, clinical chemistry, coagulation and urinalysis), or any histopathologic changes. Therefore, dietary exposure to 2'-fucosyllactose at concentrations up to 2000 mg/L was well tolerated by neonatal farm piglets and did not result in adverse health effects or impact piglet growth.


Subject(s)
Trisaccharides/toxicity , Animals , Animals, Newborn , Body Weight/drug effects , Diet , Eating/drug effects , Female , Growth/drug effects , Male , Organ Size/drug effects , Swine
9.
Nucl Med Rev Cent East Eur ; 17(2): 65-9, 2014.
Article in English | MEDLINE | ID: mdl-25088104

ABSTRACT

BACKGROUND: ¹²³I-FP-CIT (DaTSCAN) SPECT studies of the nigrostriatal pathway are a valuable tool in the diagnosis of movement disorders. However some scans are reported as equivocal with potential adverse consequences. We investigated whether the use of quantification of tracer uptake within the striatum can be used to reduce the number of equivocal reports. MATERIAL AND METHODS: BRASS software (Hermes, Sweden) was used to quantify striatal tracer uptake in DaTSCAN studies of patients referred to our institution. Scans were quantified and numerical limits were determined to distinguish between normal and abnormal scans. Scans were then re-reported both with, and without, the use of quantification. Number of equivocal reports and accuracy of reporting between the two types of reporting were compared. RESULTS: Scan reporting using quantification led to a significant reduction in the number of equivocal reports with no significant change in reporting accuracy. CONCLUSION: Automated quantification of DaTSCAN studies with BRASS and the use of numerical limits can decrease the number of equivocal reports without affecting report accuracy.


Subject(s)
Image Processing, Computer-Assisted/methods , Research Report , Software , Tomography, Emission-Computed, Single-Photon/methods , Tropanes , Aged , Automation , Female , Humans , Male , Movement Disorders/diagnostic imaging , Sensitivity and Specificity
10.
Nutr Cancer ; 64(7): 1038-48, 2012.
Article in English | MEDLINE | ID: mdl-23061907

ABSTRACT

Vegetables of the Cruciferae family contain high levels of glucosinolates, metabolites of which are believed to enhance detoxification. Spanish black radishes (SBR) contain 4× more glucosinolates than other crucifers. This study examined whether feeding mice a diet containing 20% SBR for 2 wk could enhance metabolism of 7,12-dimethylbenz(a)anthracene (DMBA) and inhibit DMBA-mediated bone marrow toxicity. Expression of Phase I and II detoxification enzymes was significantly greater for mice fed SBR than control diet. Six hours after DMBA administration, the blood levels of DMBA in mice fed the SBR diet were significantly lower than mice fed a control diet. DMBA reduced bone marrow cells in mice fed control diet to a significantly greater extent than mice fed the SBR diet. Colony forming assays demonstrated that mice on the SBR diet had 1) less reduction in lymphoid CFU-preB progenitor cells, 2) greater recovery of CFU-preB progenitor cells at 168 h, and 3) less reduction of CFU-GM progenitor cells at 6 h. Therefore, mice fed a 20% SBR diet for 2 wk had greater expression of detoxification enzymes, faster metabolism of DMBA, and a reduction in DMBA-induced bone marrow toxicity. Overall, these results support the hypothesis that glucosinolates in SBR are protective against acute toxicity.


Subject(s)
9,10-Dimethyl-1,2-benzanthracene/pharmacokinetics , Bone Marrow Cells/drug effects , Diet , Granulocyte-Macrophage Progenitor Cells/drug effects , Raphanus , 9,10-Dimethyl-1,2-benzanthracene/toxicity , Animals , Bone Marrow Cells/metabolism , Dose-Response Relationship, Drug , Female , Glucosinolates/pharmacology , Granulocyte-Macrophage Progenitor Cells/metabolism , Mice , Mice, Inbred C57BL , Plant Extracts/pharmacology , Real-Time Polymerase Chain Reaction , Spain
11.
J Food Sci ; 76(1): C185-92, 2011.
Article in English | MEDLINE | ID: mdl-21535648

ABSTRACT

Radishes (Raphanus sativus L.) are members of the cruciferous vegetable family that contain many classes of biologically active phytochemicals. This study determined the phytochemical composition of the sprouts and mature taproots of 8 radish varieties. Radish sprouts contained significantly greater concentrations of glucosinolates (3.8-fold) and isothiocyanates (8.2-fold) than the mature radish taproot and also contained significantly greater concentrations of phenolics (on average 6.9-fold). The anthocyanin concentrations of the mature radish taproot were significantly greater than in the sprouts of red, pink, and purple varieties. The primary anthocyanidins present in the red and pink radish varieties were pelargonidin and delphinidin, while the primary anthocyanidin in the purple radish variety was cyanidin. Radish sprouts were between 9- and 59-fold more potent than the corresponding mature taproot at activating the antioxidant response element (ARE) in a stably transfected hepatoma cell line. The ARE activity of the radish sprouts and mature taproots was significantly correlated with the total isothiocyanate concentration of the radishes. Practical Application: Understanding the influence variety and developmental stage has on the biological activity of cruciferous vegetables provides important information for further studies examining the in vivo effects of radish treatment and foundation for providing recommendations to reduce the risk of chronic disease through dietary intervention.


Subject(s)
Anticarcinogenic Agents/analysis , Anticarcinogenic Agents/pharmacology , Antioxidants/analysis , Antioxidants/pharmacology , Plant Roots/chemistry , Raphanus/chemistry , Seedlings/chemistry , Carcinoma, Hepatocellular/prevention & control , Chromatography, High Pressure Liquid , Flavonoids/analysis , Flavonoids/pharmacology , Genes, Reporter , Glucosinolates/analysis , Glucosinolates/pharmacology , Hep G2 Cells , Humans , Isothiocyanates/analysis , Isothiocyanates/pharmacology , Liver Neoplasms/prevention & control , Osmolar Concentration , Phenols/analysis , Phenols/pharmacology , Pigmentation , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Roots/growth & development , Polyphenols , Raphanus/growth & development , Response Elements/drug effects , Seedlings/growth & development , Species Specificity
12.
J Food Sci ; 76(3): C454-61, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21535814

ABSTRACT

UNLABELLED: The bioactive metabolites of glucosinolates, such as isothiocyanates, contained in cruciferous vegetables have been shown to reduce the risk of cancers through the induction of detoxification enzymes. However, cruciferous vegetables are commonly processed before consumption, significantly altering the phytochemical composition of these vegetables. Compared to freeze-dried Brussels sprouts, oven-dried Brussels sprouts contain low concentrations of glucosinolates (22.14 and 0.85 µmol/g, respectively) and isothiocyanates (3.68 and 0.15 µmol/g, respectively). The effect of oven-dried Brussels sprouts on the expression of detoxification enzymes was evaluated in vitro and in vivo. Treatment of immortalized human hepatoma cells with the aqueous extract from oven-dried Brussels sprouts significantly increased quinone activity (0.5 and 1.5 mg/mL) and the activity of the antioxidant response element (EC50=2.39 mg/mL) and xenobiotic response element (EC50 2.92 mg/mL). C3H/HeJ mice fed a diet containing 20% oven-dried Brussels sprout diets for 2 wk demonstrated significantly higher expression than animals fed a nutrient-matched control diet of CYP1A1, CYP1A2, and epoxide hydrolase in the liver and CYP1A1, CYP1A2, CYP1B1, epoxide hydrolase, UGT1A1, thioredoxin reductase, and heme oxygenase in the lungs. The low concentrations of glucosinolates and isothiocyanates in oven-dried Brussels sprouts suggest that other compounds, such as the Maillard reaction products that are produced during heating, are responsible for the induction of detoxification enzymes in vitro and in vivo. PRACTICAL APPLICATION: The manner in which cruciferous vegetables are processed prior to consumption has significant effects on what compounds people are exposed to. The presence of glucosinolates or isothiocyanates can be a good indicator of the ability of cruciferous vegetables to induce detoxification enzymes. However, the data presented here demonstrate that while heat processing of Brussels sprouts greatly reduced the concentrations of glucosinolates and isothiocyanates, their ability to induce detoxification enzymes in vitro and in vivo was retained.


Subject(s)
Brassica/chemistry , Food Handling , Hot Temperature , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Shoots/chemistry , Animals , Anticarcinogenic Agents/chemistry , Anticarcinogenic Agents/pharmacology , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/prevention & control , Cell Line, Tumor , Enzyme Induction/drug effects , Glucosinolates/analysis , Hot Temperature/adverse effects , Humans , Isothiocyanates/analysis , Liver/enzymology , Liver/metabolism , Liver Neoplasms/drug therapy , Liver Neoplasms/metabolism , Liver Neoplasms/prevention & control , Lung/enzymology , Lung/metabolism , Male , Mice , Mice, Inbred C3H , RNA, Messenger/metabolism , Random Allocation , Response Elements/drug effects
13.
J Food Sci ; 76(3): C504-11, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21535821

ABSTRACT

UNLABELLED: The biological activity of cruciferous vegetables is hypothesized to be due to the metabolites of a class of phytochemicals called glucosinolates. The chemical properties of these metabolites, including isothiocyanates, determine the biological activity of these compounds and thus their effects on human health. The 2 primary radish (Raphanus sativus L.) glucosinolates, glucoraphasatin, and glucoraphenin, were isolated using solid phase extraction followed by preparative HPLC purification. In an aqueous environment, 77.6% of the maximum amount of sulforaphene produced by the metabolism of glucoraphenin was present after 24 h. Under the same conditions raphasatin, the isothiocyanate metabolite of glucoraphasatin and the oxidized counterpart of sulforaphene, was highly unstable with a half-life of less than 30 min and no raphasatin was detectable after 24 h. In HepG2 cells, raphasatin-induced quinone reductase activity and the RNA expression of several phase 1 and 2 detoxification enzymes by a significantly greater amount than the degradation products of raphasatin. Raphasatin, but not its degradation products, activated the antioxidant response element (ARE) in a stably-transfected reporter cell line. Mice fed a diet consisting of 20% freeze dried radishes for 2 wk had significantly higher liver expression of cytochrome P450 (CYP) 1A1, 1A2, quinone reductase, microsomal epoxide hydrolase, and glutathione S-transferase α2 than mice fed a nutritionally-matched control diet. PRACTICAL APPLICATION: Glucoraphasatin, the primary glucosinolate in radishes, is metabolized into an isothiocyanate (raphasatin) that has biological activity but is also unstable in an aqueous environment. Despite the instability of raphasatin, dietary exposure to radishes produced significant induction of detoxification enzymes. Understanding the chemical properties of raphasatin, both in terms of biological activity and instability, could help develop processing methods to retain the most activity from radishes, glucoraphasatin, and raphasatin.


Subject(s)
Antioxidants/metabolism , Antioxidants/pharmacology , Cytochrome P-450 Enzyme System/biosynthesis , Hepatocytes/drug effects , Isothiocyanates/metabolism , Isothiocyanates/pharmacology , Oxidoreductases/biosynthesis , Animals , Cytochrome P-450 Enzyme System/genetics , Enzyme Induction/drug effects , Genes, Reporter , Glucosinolates/isolation & purification , Glucosinolates/metabolism , Half-Life , Hep G2 Cells , Hepatocytes/enzymology , Hepatocytes/metabolism , Humans , Male , Mice , Oxidation-Reduction , Oxidoreductases/metabolism , Plant Roots/chemistry , RNA, Messenger/metabolism , Random Allocation , Raphanus/chemistry , Response Elements/drug effects
14.
J Food Sci ; 75(6): H190-9, 2010 Aug 01.
Article in English | MEDLINE | ID: mdl-20722931

ABSTRACT

In cruciferous vegetables, myrosinase metabolizes the relatively inactive glucosinolates into isothiocyanates and other products that have the ability to increase detoxification enzyme expression. Thus, maintaining myrosinase activity during food preparation may be critical to receiving the maximum benefit of consumption of Brussels sprouts or other cruciferous vegetables. To test the importance of maintaining myrosinase activity for maximizing bioactivity, experimental diets containing 20% unblanched (active myrosinase) or 20% blanched (inactivated myrosinase) freeze-dried Brussels sprouts and a nutrient-matched control diet were evaluated in vitro and in vivo for their ability to induce detoxification enzymes. Treatment of immortalized HepG2 human hepatoma cells with the unblanched Brussels sprout diet caused a greater increase quinone activity compared to the blanched Brussels sprout diet. C3H/HeJ mice fed the unblanched Brussels sprout diets for 2 wk had significantly higher plasma sulforaphane concentrations. Liver expression of CYP1A1 and epoxide hydrolase, measured using real-time PCR, was correlated with the plasma concentration of sulforaphane. In the lung, expression of epoxide hydrolase, thioredoxin reductase, UDP glucuronosyltransferase, quinone reductase, heme oxygenase, CYP1A1, CYP1A2, and CYP1B1 were also correlated with the plasma concentration of sulforaphane. Together these data demonstrate that, as predicted by the in vitro experiment, in vivo exposure to Brussels sprouts with active myrosinase resulted in greater induction of both phase I and phase II detoxification enzymes in the liver and the lungs that correlated with plasma sulforaphane concentrations.


Subject(s)
Brassica , Gene Expression Regulation, Enzymologic , Glycoside Hydrolases/metabolism , Liver/enzymology , Lung/enzymology , Plant Proteins, Dietary/metabolism , Thiocyanates/blood , Animals , Brassica/chemistry , Brassica/enzymology , Cytochrome P-450 CYP1A1/genetics , Cytochrome P-450 CYP1A1/metabolism , Enzyme Induction , Epoxide Hydrolases/genetics , Epoxide Hydrolases/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Glucosinolates/analysis , Glucosinolates/metabolism , Hep G2 Cells , Hot Temperature , Humans , Inactivation, Metabolic , Isothiocyanates/analysis , Liver/drug effects , Male , Mice , Mice, Inbred C3H , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Leaves/chemistry , Plant Leaves/enzymology , Quinone Reductases/genetics , Quinone Reductases/metabolism , RNA, Messenger/metabolism , Sulfoxides , Thiocyanates/metabolism
15.
BMC Complement Altern Med ; 9: 51, 2009 Dec 14.
Article in English | MEDLINE | ID: mdl-20003431

ABSTRACT

BACKGROUND: Congaplex and Immuplex are dietary supplements that have been traditionally used to support immune system function. The purpose of these experiments was to determine whether Congaplex and Immuplex affect immune function using primary and immortalized T lymphocytes. METHODS: Immortalized CEM and Jurkat T lymphocytes and primary peripheral mononuclear blood cells (PBMCs) were treated with the aqueous extracts from Congaplex and Immuplex to determine the effects of these products on cytokine production in activated T lymphocytes. RESULTS: Congaplex enhanced phytohemagglutinin/phorbol 12-myristate 13-acetate (PHA/PMA) stimulation of both CEM and Jurkat cells as measured by the production of cytokines, while Immuplex suppressed PHA/PMA-induced production of cytokines, with the exception of interleukin (IL)-8 which was enhanced by Immuplex. In vitro treatment of PBMCs from 10 healthy donors with Congaplex or Immuplex decreased PHA-stimulated production of interferon (IFN)-gamma but increased the production of IL-13. CONCLUSIONS: While the effects of Congaplex and Immuplex differed in these two models, these data demonstrate that the aqueous extracts from these two dietary supplements can affect the inflammatory response of T lymphocytes.


Subject(s)
Cytokines/biosynthesis , Dietary Supplements , Immunologic Factors/pharmacology , Phytotherapy , T-Lymphocytes/drug effects , Cell Line , Drug Combinations , Humans , Interferon-gamma/biosynthesis , Interleukin-13/biosynthesis , Interleukin-8/biosynthesis , Jurkat Cells , Micronutrients/pharmacology , Phytohemagglutinins/pharmacology , Plant Extracts/pharmacology , RNA, Messenger/biosynthesis , T-Lymphocytes/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Thymus Extracts/pharmacology
16.
J Agric Food Chem ; 55(16): 6439-46, 2007 Aug 08.
Article in English | MEDLINE | ID: mdl-17616135

ABSTRACT

Spanish black radish (Raphanus sativus L. var. niger) is a member of the Cruciferae family that also contains broccoli and Brussels sprouts, well-known to contain health-promoting constituents. Spanish black radishes (SBR) contain high concentrations of a glucosinolate unique to the radish family, glucoraphasatin, which represents >65% of the total glucosinolates present in SBR. The metabolites of glucosinolates, such as isothiocyanates, are implicated in health promotion, although it is unclear whether glucosinolates themselves elicit a similar response. The crude aqueous extract from 0.3 to 3 mg of dry SBR material increased the activity of the phase II detoxification enzyme quinone reductase in the human hepatoma HepG2 cell line with a maximal effect at a concentration of 1 mg/mL. Treatment of HepG2 cells with the crude aqueous extract of 1 mg of SBR per mL also significantly induced the expression of mRNA corresponding to the phase I detoxification enzymes: cytochrome P450 (CYP) 1A1, CYP1A2, and CYP1B1 as well as the phase II detoxification enzymes: quinone reductase, heme oxygenase 1, and thioredoxin reductase 1. Previous studies have shown that the myrosinase metabolites of different glucosinolates vary in their ability to induce detoxification enzymes. Here, we show that while glucoraphasatin addition was ineffective, the isothiocyanate metabolite of glucoraphasatin, 4-methylthio-3-butenyl isothiocyanate (MIBITC), significantly induced phase II detoxification enzymes at a concentration of 10 microM. These data demonstrate that the crude aqueous extract of SBR and the isothiocyanate metabolite of glucoraphasatin, MIBITC, are potent inducers of detoxification enzymes in the HepG2 cell line.


Subject(s)
Inactivation, Metabolic , Liver/enzymology , Plant Extracts/pharmacology , Raphanus/chemistry , Carcinoma, Hepatocellular , Cell Line, Tumor , Cytochrome P-450 Enzyme System/biosynthesis , Enzyme Induction/drug effects , Humans , Liver Neoplasms , NAD(P)H Dehydrogenase (Quinone)/biosynthesis , Water
17.
Nature ; 441(7093): 585, 2006 Jun 01.
Article in English | MEDLINE | ID: mdl-16738650
18.
Toxicol Appl Pharmacol ; 207(1): 39-58, 2005 Aug 22.
Article in English | MEDLINE | ID: mdl-16054899

ABSTRACT

C3H10T1/2 mouse embryo fibroblasts differentiate into adipocytes when stimulated by a standard hormonal mixture (IDMB). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), via the aryl hydrocarbon receptor (AhR), inhibits induction of the key adipogenic gene peroxisome proliferator-activated receptor gamma (PPARgamma) and subsequent adipogenesis. This TCDD-mediated inhibition requires activation of the extracellular signal-regulated kinase (ERK) pathway, which can be accomplished by serum, epidermal growth factor (EGF), or fibroblast growth factor (FGF). In the absence of serum or growth factors, IDMB induced adipogenesis without mitosis. Microarray analysis identified 200 genes that exhibited expression changes of at least twofold after 24 h of IDMB treatment. This time precedes most PPARgamma stimulation but follows the period of TCDD/ERK cooperation and periods of increased cell contraction and DNA synthesis. Functionally related gene clusters include genes associated with cell structure, triglyceride and cholesterol metabolism, oxidative regulation, and secreted proteins. In the absence of growth factors TCDD inhibited 30% of these IDMB responses without inhibiting the process of differentiation. A combination of EGF and TCDD that blocks differentiation cooperatively blocked a further 44 IDMB-responsive genes, most of which have functional links to differentiation, including PPARgamma. Cell cycle regulators that are stimulated by EGF were substantially inhibited by IDMB but these responses were unaffected by TCDD. By contrast, TCDD and EGF cooperatively reversed IDMB-induced changes in cell adhesion complexes immediately prior to increases in PPARgamma1 expression. Changes in adhesion-linked signaling may play a key role in TCDD affects on differentiation.


Subject(s)
Adipocytes/drug effects , Cell Differentiation/drug effects , Epidermal Growth Factor/pharmacology , Oligonucleotide Array Sequence Analysis , Polychlorinated Dibenzodioxins/pharmacology , Adipocytes/cytology , Animals , Cell Adhesion , Cell Division , Cell Line , Fibroblast Growth Factors/pharmacology , Gene Expression Profiling , Lipids/biosynthesis , Mice , Oxidation-Reduction , PPAR gamma/genetics , Receptors, Aryl Hydrocarbon/physiology
19.
FASEB J ; 19(10): 1323-5, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15946993

ABSTRACT

Langendorff-perfused rat hearts treated with EPO exhibited significantly improved postischemic recovery of left ventricular developed pressure (LVDP) and reduced infarct size compared with control hearts. Perfusion with the mitogen/extracellular signal-regulated kinase (MEK) inhibitor U0126 just before and concomitant with EPO treatment abolished EPO-induced phosphorylation of the MEK substrate extracellular signal-regulated kinase (ERK) but had no effect of EPO-mediated cardioprotection. EPO treatment of the perfused hearts induced translocation of protein kinase C (PKC) epsilon isoform to the membrane fraction of the hearts and the protective effect of EPO was significantly inhibited by the PKC catalytic inhibitor chelerythrine added before and concomitant with EPO. These data demonstrate that EPO-mediated activation of the PKC signaling pathway before or during ischemia is required for the cardioprotective effect of EPO during ischemia-reperfusion injury. Perfusion with the phosphatidylinositol 3-kinase (PI3K) inhibitors LY294002 or wortmannin just before and concomitant with EPO treatment attenuated EPO-induced phosphorylation of the PI3K substrate Akt but had no effect on EPO-mediated cardioprotection. However, when wortmannin was added during EPO treatment and continued during reperfusion, EPO-mediated cardioprotection was significantly inhibited. We also show that postischemia EPO treatment at the onset of reperfusion significantly improved recovery of LVDP and reduced infarct size. Postischemia cardioprotection by EPO required the PI3K pathway but was not affected by inhibition of PKC at the time of EPO treatment.


Subject(s)
Erythropoietin/pharmacology , Myocardial Reperfusion Injury/prevention & control , Phosphatidylinositol 3-Kinases/physiology , Protein Kinase C/physiology , Signal Transduction/physiology , Alkaloids , Androstadienes/pharmacology , Animals , Benzophenanthridines , Chromones/pharmacology , Extracellular Signal-Regulated MAP Kinases/physiology , Male , Morpholines/pharmacology , Myocardial Infarction/prevention & control , Phenanthridines/pharmacology , Proto-Oncogene Proteins c-akt/physiology , Rats , Rats, Sprague-Dawley , Recombinant Proteins , Ventricular Function, Left/drug effects , Wortmannin
20.
Arch Biochem Biophys ; 439(2): 139-53, 2005 Jul 15.
Article in English | MEDLINE | ID: mdl-15967407

ABSTRACT

Stimulation of C3H10T1/2 cells by an adipogenic hormonal mixture (IDM) consisting of insulin (I), dexamethasone (D), and methylisobutylxanthine (M) substantially induces cytochrome P450 (CYP) 1B1 expression. This stimulation represents up to 40% of the level produced by maximum activation of the arylhydrocarbon receptor (AhR) with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Dexamethasone and methylisobutylxanthine in combination produced near maximum elevation of CYP1B1 along with a subsequent decline in AhR that paralleled the rise in peroxisome proliferator-activated receptorgamma1 (PPARgamma1). Inhibitors of AhR activity, which block TCDD induction, did not affect this increase of CYP1B1 expression, which was, therefore, independent of AhR activity. These responses were unaffected by inhibition of DNA synthesis, which was required for PPARgamma1 induction and terminal differentiation. Induction of CYP1B1 mRNA was paralleled by increased CYP1B1 promoter-luciferase reporter activity. The initial 0.8kb of promoter region, which was sufficient for 24h near maximum stimulation, did not contain either the key AhR-responsive elements that mediate the TCDD response or CREB and SF1 elements that mediate cAMP stimulation of rat CYP1B1 in steroidogenic cells. This reporter response to IDM stimulation, but not to TCDD, was maintained in AhR-null fibroblasts. CYP1B1 expression, unlike TCDD induction, was stimulated by IDM in only about half the cells. CYP1B1 expression partially overlapped with PPARgamma expression, which was also inversely related in clonal sub-lines. CYP1B1 expression may, therefore, represent an early stage of differentiation that requires factors associated with DNA synthesis to subsequently generate PPARgamma1.


Subject(s)
Aryl Hydrocarbon Hydroxylases/metabolism , Cell Differentiation/physiology , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/metabolism , Receptors, Aryl Hydrocarbon/metabolism , 1-Methyl-3-isobutylxanthine/pharmacology , Adipocytes/cytology , Adipocytes/drug effects , Adipocytes/metabolism , Animals , Aryl Hydrocarbon Hydroxylases/drug effects , Aryl Hydrocarbon Receptor Nuclear Translocator , CCAAT-Enhancer-Binding Protein-alpha/drug effects , CCAAT-Enhancer-Binding Protein-alpha/metabolism , CCAAT-Enhancer-Binding Protein-beta/drug effects , CCAAT-Enhancer-Binding Protein-beta/metabolism , Cell Differentiation/drug effects , Cells, Cultured , Cyclic AMP Response Element-Binding Protein/drug effects , Cyclic AMP Response Element-Binding Protein/metabolism , Cytochrome P-450 CYP1B1 , DNA/biosynthesis , DNA/drug effects , DNA-Binding Proteins/drug effects , DNA-Binding Proteins/metabolism , Dexamethasone/pharmacology , Drug Synergism , Fibroblasts/drug effects , Mice , PPAR gamma/drug effects , PPAR gamma/metabolism , Pluripotent Stem Cells/drug effects , Polychlorinated Dibenzodioxins/pharmacology , Promoter Regions, Genetic , Receptors, Aryl Hydrocarbon/antagonists & inhibitors , Receptors, Aryl Hydrocarbon/drug effects , Response Elements/drug effects , Transcription Factors/drug effects , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...